Nicola Fazio
尼古拉·法齐奥
MD, PhD
Head of Gastrointestinal and Neuroendocrine Tumor Unit胃肠及神经内分泌肿瘤科主任
👥Biography 个人简介
Dr. Nicola Fazio leads the NET program at the European Institute of Oncology in Milan, focusing on systemic therapies for advanced NETs. He has contributed substantially to chemotherapy and targeted therapy trials in poorly differentiated neuroendocrine carcinomas and pancreatic NETs.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Chemotherapy in Neuroendocrine Carcinomas
Conducted systematic research on platinum-based chemotherapy regimens for poorly differentiated neuroendocrine carcinomas, defining response predictors and optimal treatment sequencing.
Multidisciplinary NET Care
Developed a multidisciplinary NET tumor board model at IEO Milan integrating oncology, surgery, nuclear medicine, and endocrinology, adopted as a model across Italian cancer centers.
Representative Works 代表性著作
Chemotherapy in gastroenteropancreatic (GEP) neuroendocrine carcinomas: a critical view
Cancer Treatment Reviews (2013)
Systematic critical appraisal of chemotherapy evidence in poorly differentiated GEP neuroendocrine carcinomas, highlighting evidence gaps and guiding future trial design.
Temozolomide in patients with advanced neuroendocrine tumors and carcinomas
Journal of Clinical Oncology (2016)
Multicenter study demonstrating temozolomide activity in various NET subtypes, supporting its use in treatment algorithms for refractory NET.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
James Yao
MD Anderson Cancer Center
Matthew Kulke
Boston Medical Center / Boston University
Emily Bergsland
University of California, San Francisco (UCSF)
Eric Liu
Rocky Mountain Cancer Centers
关注 尼古拉·法齐奥 的研究动态
Follow Nicola Fazio's research updates
留下邮箱，当我们发布与 Nicola Fazio（European Institute of Oncology (IEO), Milan）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment